ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.185
-0.11%
Bitcoin
66,667.66
0.72%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Humacyte Inc (HUMA)

  7. Humacyte Inc (HUMA) News

Humacyte (HUMA)

Humacyte Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HUMA
DateTimeSourceHeadlineSymbolCompany
08/03/202421:03Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:HUMAHumacyte Inc
04/03/202411:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
29/02/202421:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:HUMAHumacyte Inc
29/02/202421:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
09/02/202413:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
12/12/202321:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
12/12/202321:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
12/12/202321:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
12/12/202321:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
12/12/202321:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
12/12/202321:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
12/12/202321:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
12/12/202313:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
09/11/202321:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HUMAHumacyte Inc
09/11/202321:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
10/10/202321:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
10/10/202321:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
15/09/202321:09Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:HUMAHumacyte Inc
15/09/202321:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
15/09/202321:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
12/09/202312:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
12/09/202301:03Dow Jones NewsStocks to Watch: Oracle, Acelyrin, HumacyteNASDAQ:HUMAHumacyte Inc
21/08/202323:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
21/08/202323:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
21/08/202323:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
17/08/202321:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HUMAHumacyte Inc
14/08/202313:44Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HUMAHumacyte Inc
14/08/202312:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
31/07/202318:28Dow Jones NewsHumacyte Shares Rise 8% After Completing Enrollment in Phase 2/3 TrialNASDAQ:HUMAHumacyte Inc
26/07/202313:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
 Showing the most relevant articles for your search:NASDAQ:HUMA

Your Recent History

LSE
PANR
Pantheon Resources
LSE
LLOY
Lloyds Banking
LSE
EEE
Empire Metals
LSE
GOLD
LSE
GKP
Gulf Keystone Petroleum
LSE
VAST
Vast Resources
LSE
ARCM
Arc Minerals
LSE
BIRD
Blackbird
LSE
ENET
Ethernity Networks
LSE
TW.
Taylor Wimpey
LSE
QBT
Quantum Blockchain Techn...
LSE
NEXN
Nexxen
LSE
SDRY
Superdry
LSE
AFC
Afc Energy
LSE
SRSP
Sirius Petroleum
LSE
HE1
Helium One Global
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved